4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Lantern Pharma Inc. (LTRN) operates in the Biotechnology industry and is headquartered in Dallas, United States with about 16 employees. Its market capitalization is roughly $37 million. In the fiscal year ended 2025-12-31, LTRN reported $0M in revenue and ($17M) in net income.
Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($18M) | ($22M) | ($18M) | ($14M) |
| Net Income | ($17M) | ($21M) | ($16M) | ($14M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($3M) | ($4M) | ($4M) | ($5M) | ($5M) |
| Net Income | ($3M) | ($4M) | ($4M) | ($4M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $11M | $26M | $44M | $59M | — |
| Total Liabilities | $4M | $4M | $3M | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LTRN viewer.
About TickerBase · Data methodology & sources